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INTRODUCTION 
Cellulite is characterized by lumpy, dimpled flesh on the thighs, hips, buttocks and abdomen, 
(Fig.1), sometimes described as orange peel texture (1). Although not a serious medical condition, 
but rather an aesthetical concern of many adolescent and adult women, it can impact significantly 
in their self-esteem. Many cellulite treatments are conducted without counseling and supervision of 
a health professional, disregarding possible interaction with drugs or contraindications due to a pre-
existing medical condition. Moreover, remarkable results are advertised and most of these 
treatments have few scientific support (2,3) and do not live up to their claims.  
Anti-cellulite products can be either TOPICAL (COSMETICS) or ORAL (FOOD SUPPLEMENTS), and 
their consumption pattern and efficacy perception are evaluated in this pilot work. 
MATERIALS AND METHODS 
Anonymous questionnaire (n=86), 
validated and approved by Egas Moniz 
ethics committee, was applied in 
pharmacies (May-August 2017), to women 
≥15 years old. Sample was characterized 
regarding socioeconomic status and, 
those who had already used an anti-
cellulite product, were asked about 
preference (oral/topical), acquisition 
place, counseling, results obtained upon 
treatment and efficacy perception. 
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RESULTS 
The sample was mainly in the age groups of 18-34 (41.86%), 35-55 years (31.40%) and above 56 (20.93%); none of the respondents was bellow 
18. Women held a secondary degree (24.42%) or higher (51.18%), lived in the city (69.77%) and considered their economic level as average 
(74.42%).  
Regarding consumption (Fig.2), 41.86% had already used a topical (77.22%), oral (5.56%) or a combination of both (19.44%) products; these 
were bought mainly in the pharmacy (72.22%), equally used seasonally/randomly (44.44%), mainly under pharmaceutical counseling 
(50.00%). However, 36.12% reported using the products at their own accord, without intervention of any health professional. Oral products 
were considered more effective than topical (11.11% vs 5.56%), although 38.89% were deemed to be equally effective and 44.44% did not 
know. Most women (69.44%) considered to have obtained results from the treatment, though sometimes below the expected (33.33%). 
DISCUSSION AND CONCLUSIONS 
 The study has shown that women below 55 years old, with a higher education degree, are the greatest consumers of anti-cellulite 
products, which are mainly acquired in the pharmacy, though sometimes without pharmaceutical advice.  
 While considered more efficacious (either alone or in combination with topical), food supplements were less consumed than cosmetics, 
probably due to the increased risk perception associated with the first. In fact, anti-cellulite products, especially those marketed as food 
supplements, are not without adverse effects and contraindications.  
 Pharmaceutical counseling on dispensing anti-cellulite products is thus critical and should be regarded as a differentiating factor of the 
place of acquisition and an added-value to the product.  
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Fig. 2. Consumption of anti-cellulite products regarding USE (A), PREFERENCE (B), PERIODICITY OF USE (C), COUNSELLING (D) AND EFFICACY PERCEPTION (E).  
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